1. Home
  2. PI vs VERA Comparison

PI vs VERA Comparison

Compare PI & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Impinj Inc.

PI

Impinj Inc.

HOLD

Current Price

$124.11

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$36.42

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PI
VERA
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.2B
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
PI
VERA
Price
$124.11
$36.42
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$176.38
$81.30
AVG Volume (30 Days)
349.5K
1.2M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$122,633,000.00
N/A
Revenue This Year
$4.26
N/A
Revenue Next Year
$25.04
$472.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$87.96
$18.76
52 Week High
$247.06
$56.05

Technical Indicators

Market Signals
Indicator
PI
VERA
Relative Strength Index (RSI) 64.31 34.12
Support Level $106.38 $20.11
Resistance Level $131.82 $42.77
Average True Range (ATR) 5.69 2.28
MACD 1.77 -0.63
Stochastic Oscillator 89.38 5.39

Price Performance

Historical Comparison
PI
VERA

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: